After Mixed Q2 Report, Novavax Analyst Details Possible Coronavirus Vaccine Catalysts
August 11, 2020 at 13:49 PM EDT
An analyst at H.C. Wainwright said they're focusing on the key milestone events for the company's coronavirus vaccine candidate after the print.
